Drotrecogin alfa (activated) (Xigris, marketed by Eli Lilly and Company) is a recombinant form of human activated protein C that has anti-thrombotic, anti-inflammatory...

of a recombinant form of human Activated Protein C (rhAPC) known as Drotrecogin alfa-activated, branded Xigris by Eli Lilly and Company, has been surrounded...

activated protein C, was produced in recombinant form and marketed as Drotrecogin alfa (also known as Xigris (TM)) and licensed for intensive-care treatment...

mortality and to increase bleeding, and thus, was not recommended for use. Drotrecogin alfa (Xigris), was withdrawn from the market in October 2011. Sepsis has...

was previously recommended in those with severe sepsis and DIC, but drotrecogin alfa has been shown to confer no benefit and was withdrawn from the market...

Archived from the original on 1 February 2014. Retrieved 26 January 2014. Drotrecogin Alfa (Activated) in Adults with Septic Shock Archived 2015-09-29 at the...

B01AD09 Ancrod B01AD10 Drotrecogin alfa (activated) B01AD11 Tenecteplase B01AD12 Protein C B01AD13 Apadamtase alfa and cinaxadamtase alfa B01AE01 Desirudin...

wafer chemotherapy Interstitial/ intracavitary (00.11) Infusion of drotrecogin alfa (activated) Infusion of recombinant protein (00.12) Administration...

drospirenone (INN) drostanolone (INN) drotaverine (INN) drotebanol (INN) drotrecogin alfa (INN) droxacin (INN) Droxia droxicainide (INN) droxicam (INN) droxidopa...

study in matched patients with severe sepsis treated with or without drotrecogin Alfa (activated)". Annals of Intensive Care. 2 (1): 15. doi:10.1186/2110-5820-2-15...